Ethyl (1R,2R)-2'-oxospiro[cyclopropane-1,3'-indoline]-2-carboxylate, 98%, 250mg

5-Bromo-2-methoxy-4-methylpyridine, 98.0%, 25g

ROTI®Cell RPMI-1640

(1,3-benzothiazol-2-ylmethyl)methylamine, 95.0%, 25g

N,N'-1,4-Phenylenebisacetamide, 98.0%, 5g

5-Benzenesulfonyl-5H-pyrrolo[3,2-d]pyrimidine-6-carboxylic acid, 95.0%, 250mg

Benzenemethanesulfonamide, N-[2-(dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]-, 200mg

3-[(prop-2-ynylamino)sulfonyl]benzoic acid, 100mg

2,5-Bis(morpholinomethyl)benzene-1,4-diol, 95.0%, 25mg

2-(Tetrahydro-2H-pyran-4-yl)ethanamine hydrochloride, 95.0%, 250mg

(E)-Methyl 4-aminobut-2-enoate hydrochloride, 97%, 250mg

Tert-butyl 3-chloropropanoate, 98+%, 50mg

3-Amino-2-chloro-5-fluoropyridine, 95.0%, 1g